This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 18 CIPO patents and 4 EPO patents. Top assignees: Replicor Inc, Other. Active years: 2008-2017.
Company Filing History:
11 out of 11 
2 out of 834,411 Years Active: 2008-2017
Title: The Innovative Journey of Inventor Andrew Vaillant
Introduction: Andrew Vaillant, a prominent inventor based in Roxboro, California, has made significant contributions to the field of medicine with his 13 patents. His inventive spirit and dedication to addressing critical health issues have positioned him as a noteworthy figure in the biotech industry.
Latest Patents: Among his most recent patents is a groundbreaking invention concerning oligonucleotide chelate complexes. This patent describes pharmaceutical compositions and methods for treating viral infections, hypercholesterolemia, hypertriglyceridemia, Alzheimer's disease, prion disease, and Duchenne's muscular dystrophy using these innovative complexes. Another notable patent highlights methods for treating hepatitis B and hepatitis D virus infections. This invention outlines a method that entails administering a first pharmaceutically acceptable agent, comprising at least one phosphorothioated nucleic acid polymer, along with a second agent that includes at least one nucleoside/nucleotide analog HBV polymerase inhibitor to individuals requiring treatment.
Career Highlights: Throughout his career, Andrew Vaillant has worked with various biotech companies, including Replicor Inc., where he focused on developing innovative solutions for complex health issues. His extensive background contributes to his expertise in crafting useful pharmaceutical inventions.
Collaborations: Andrew has had the privilege of collaborating with esteemed professionals in his field, including Michel Bazinet and Jean-Marc Juteau. These collaborations have fostered a rich environment for generating impactful inventions and advancing medical research.
Conclusion: Andrew Vaillant's innovative contributions have the potential to transform treatment approaches for several serious health conditions. With a solid foundation of patents and collaborations, he continues to be a vital player in the ongoing quest for medical advancements. His journey exemplifies the essence of innovation in the biotech industry.